These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31952977)

  • 21. Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.
    Prins KW; Kalra R; Rose L; Assad TR; Archer SL; Bajaj NS; Weir EK; Prisco SZ; Pritzker M; Lutsey PL; Brittain EL; Thenappan T
    J Am Heart Assoc; 2020 Mar; 9(5):e015221. PubMed ID: 32079477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.
    Yoshihisa A; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Takeishi Y
    ESC Heart Fail; 2019 Apr; 6(2):291-296. PubMed ID: 30681298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating High Mobility Group Box-1 Does Not Predict Pulmonary Arterial Hypertension in Children with Congenital Heart Disease: A Prospective Cohort Study.
    Caracci B; Pehora C; Benson L; Steinberg BE; Goldenberg NM; Taylor K
    J Cardiothorac Vasc Anesth; 2024 Oct; 38(10):2356-2361. PubMed ID: 39095209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
    BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
    Diekmann F; Chouvarine P; Sallmon H; Meyer-Kobbe L; Kieslich M; Plouffe BD; Murthy SK; Lichtinghagen R; Legchenko E; Hansmann G
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.
    Chen JY; Griffiths M; Yang J; Nies MK; Damico RL; Simpson CE; Vaidya RD; Brandal S; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    J Pediatr; 2020 Aug; 223():164-169.e1. PubMed ID: 32711743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 30. Load Adaptability in Patients With Pulmonary Arterial Hypertension.
    Amsallem M; Boulate D; Aymami M; Guihaire J; Selej M; Huo J; Denault AY; McConnell MV; Schnittger I; Fadel E; Mercier O; Zamanian RT; Haddad F
    Am J Cardiol; 2017 Sep; 120(5):874-882. PubMed ID: 28705377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
    Yokokawa T; Boucherat O; Martineau S; Lemay SE; Breuils-Bonnet S; Krishna V; Kalyana-Sundaram S; Jeyaseelan J; Potus F; Bonnet S; Provencher S
    J Am Heart Assoc; 2024 Jun; 13(12):e032888. PubMed ID: 38874078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right Atrial Function in Pulmonary Arterial Hypertension.
    Querejeta Roca G; Campbell P; Claggett B; Solomon SD; Shah AM
    Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003521; discussion e003521. PubMed ID: 26514759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of tricuspid valve regurgitation in pulmonary arterial hypertension.
    Chen L; Larsen CM; Le RJ; Connolly HM; Pislaru SV; Murphy JG; McGoon MD; Frantz RP; Kane GC
    Clin Respir J; 2018 Apr; 12(4):1572-1580. PubMed ID: 28905517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension.
    Newman JH; Brittain EL; Robbins IM; Hemnes AR
    Chest; 2015 Apr; 147(4):1080-1085. PubMed ID: 25340330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
    Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
    Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
    Gao L; Skinner J; Nath T; Lin Q; Griffiths M; Damico RL; Pauciulo MW; Nichols WC; Hassoun PM; Everett AD; Johns RA
    Respir Res; 2024 Jun; 25(1):235. PubMed ID: 38844967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function.
    Badagliacca R; Poscia R; Pezzuto B; Papa S; Gambardella C; Francone M; Mezzapesa M; Nocioni M; Nona A; Rosati R; Sciomer S; Fedele F; Dario Vizza C
    J Heart Lung Transplant; 2015 Mar; 34(3):381-9. PubMed ID: 25087105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Kuppahally SS; Michaels AD; Tandar A; Gilbert EM; Litwin SE; Bader FM
    Am J Cardiol; 2010 Dec; 106(11):1657-62. PubMed ID: 21094370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.
    Yang J; Nies MK; Fu Z; Damico R; Korley FK; Hassoun PM; Ivy DD; Austin ED; Everett AD
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1264-1272. PubMed ID: 27254543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.